Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells
H. Liu, C. Xu, B. H. Diplas, A. Brown, L. M. Strickland, J. Ling, R. E. McLendon, S. T. Keir, D. M. Ashley, Y. He, M. S. Waitkus
This study shows SMARCAL1 loss-of-function mutations enable ALT in telomerase-negative glioblastoma cells, promoting tumorigenesis and telomere maintenance.
bioRxiv · Sep 19, 2022Cancer Biology